Jefferies Maintains Buy on Calix, Lowers Price Target to $61

Jefferies analyst George Notter maintains Calix (NYSE:CALX) with a Buy and lowers the price target from $69 to $61.

byBenzinga Newsdesk

June 22, 2022

1 minute read

Jefferies analyst George Notter maintains Calix (NYSE:CALX) with a Buy and lowers the price target from $69 to $61.

Keybanc Maintains Underweight on Westlake, Raises Price Target to $95

By Benzinga Newsdesk

Today, 2:43 AM

Keybanc analyst Aleksey Yefremov maintains Westlake (NYSE:WLK) with a Underweight and raises the price target from $85 to $95.

WLK

The Past Week’s Notable Insider Buys Included Continental Resources, Skillz And More

By Nelson Hem

Today, 2:43 AM

Insider buying can be an encouraging signal for potential investors, especially when markets are uncertain or near highs. Current and former executives were adding to their stakes in the past week. A mobile games platform provider and a recent IPO were among companies that saw notable insider purchases.

ACGL

PyroGenesis Announces Receipt of $4M Purchase Order For The First Of Three 10-Ton Drosrite Systems From Existing Client

By Benzinga Newsdesk

Today, 2:43 AM

PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX:PYR) (NASDAQ:PYR) (FRA: 8PY), a high-tech company (hereinafter referred to as the "Company" or "PyroGenesis"), that designs, develops,

PYR

Columbia Care Announces Approval Of Business Combination With Cresco Labs At Special Meeting Of Shareholders

By Joana Scopel

Today, 2:43 AM

Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) announced that the proposed business combination with Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) was approved at its special

CCHWF

Jefferies Maintains Buy on Calix, Lowers Price Target to $61

Related Posts

Keybanc Maintains Underweight on Westlake, Raises Price Target to $95

The Past Week’s Notable Insider Buys Included Continental Resources, Skillz And More

PyroGenesis Announces Receipt of $4M Purchase Order For The First Of Three 10-Ton Drosrite Systems From Existing Client

Columbia Care Announces Approval Of Business Combination With Cresco Labs At Special Meeting Of Shareholders